BNP PARIBAS FINANCIAL MARKETS - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 101 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$179,396,000
-44.2%
9,972
-77.9%
0.00%
-100.0%
Q1 2020$321,670,000
-22.1%
45,115
+161.0%
0.00%0.0%
Q4 2019$412,790,000
-0.3%
17,286
+11.9%
0.00%0.0%
Q3 2019$414,181,000
+23.0%
15,443
+24.4%
0.00%0.0%
Q2 2019$336,846,000
-35.5%
12,416
-17.4%
0.00%0.0%
Q1 2019$521,888,000
+709.2%
15,040
+355.2%
0.00%
Q4 2018$64,494,000
-51.8%
3,304
-34.2%
0.00%
Q3 2018$133,762,000
-97.7%
5,023
-96.8%
0.00%
-100.0%
Q2 2018$5,937,293,000
+1402.2%
157,196
+1198.9%
0.01%
+900.0%
Q1 2018$395,251,000
-32.7%
12,102
+0.3%
0.00%0.0%
Q4 2017$587,519,000
+58.1%
12,069
+75.5%
0.00%0.0%
Q3 2017$371,618,000
-23.9%
6,878
+5.7%
0.00%0.0%
Q2 2017$488,244,000
+1001.5%
6,509
+475.5%
0.00%
Q1 2017$44,324,000
+10.0%
1,131
-37.0%
0.00%
Q4 2016$40,302,000
-57.2%
1,796
-56.7%
0.00%
Q3 2016$94,156,000
+104.2%
4,146
+112.2%
0.00%
Q2 2016$46,114,000
+5551.2%
1,954
+4785.0%
0.00%
Q1 2016$816,000
-100.0%
40
-99.9%
0.00%
-100.0%
Q4 2015$3,954,036,000
+117.2%
76,852
+79.9%
0.01%
+100.0%
Q3 2015$1,820,385,000
+7.6%
42,712
+15.0%
0.01%0.0%
Q2 2015$1,691,909,000
+4274.0%
37,144
+3545.1%
0.01%
Q1 2015$38,681,000
-30.1%
1,019
-53.4%
0.00%
Q3 2014$55,338,000
+3113.6%
2,189
+3610.2%
0.00%
Q2 2014$1,722,000
-52.6%
59
-58.2%
0.00%
Q4 2013$3,631,0001410.00%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 232,952$5,498,0005.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,673,727$86,700,0003.41%
Redmile Group, LLC 1,466,537$34,610,0003.31%
SECTORAL ASSET MANAGEMENT INC 1,229,382$29,013,0003.00%
HARVEY CAPITAL MANAGEMENT INC 206,530$4,874,0002.44%
Marcus Capital, LLC 75,150$1,774,0001.87%
Cormorant Asset Management, LP 396,000$9,346,0001.32%
Rail-Splitter Capital Management, LLC 221,414$5,225,0001.25%
Temasek Holdings (Private) Ltd 6,583,568$155,372,0001.21%
EMERALD MUTUAL FUND ADVISERS TRUST 636,526$15,022,0000.84%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders